AK112 Injection
AK112-301 (HARMONi)
Phase 3 small_molecule active
Quick answer
AK112 Injection for Non-Squamous Non-small Cell Lung Cancer is a Phase 3 program (small_molecule) at Summit Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Non-Squamous Non-small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active